The ResMed M Series CPAP line — which included the S8 and S9 families of devices — represented a generation of sleep therapy equipment that was, in its time, among the most capable available. Many patients still use these machines years or even a decade after they were first prescribed, either because the device continues to function or because the process of obtaining a replacement feels more complicated than it is worth. If you are in this situation, understanding what has actually changed in CPAP technology since the M Series era — and what you would gain from a current-generation device — helps you make a more informed decision about whether an upgrade is worth pursuing.
What the ResMed M Series CPAP Was
The M Series designation encompassed ResMed’s S8 and S9 platform devices, produced roughly between the mid-2000s and mid-2010s. The S9 in particular was a well-regarded device at the time of its release, offering relatively quiet operation, integrated humidification via the H5i humidifier, and the AutoSet algorithm for auto-titrating pressure delivery. It also introduced the Climate Control system with the ClimateLineAir heated tube — a meaningful comfort improvement over non-heated tubing.
These were capable machines that delivered effective therapy for millions of patients. The question of whether to upgrade is not about whether the M Series was inadequate — it was not — but about whether the gap between what those devices offer and what current devices offer is significant enough to justify the process of obtaining new equipment.
Algorithm Performance — Where the Gap Is Most Meaningful
The AutoSet algorithm in the S9 was a genuine advance over fixed-pressure CPAP at the time of its release. It adjusted pressure in response to detected respiratory events and flow limitation, allowing the device to deliver lower pressures during stable periods and higher pressures when the airway showed signs of obstruction.
Current ResMed devices — the AirSense 10 and AirSense 11 series — use substantially more sophisticated algorithms that better distinguish obstructive from central events, more accurately detect flow limitation before it progresses to a full event, and respond more smoothly to changing conditions during the night. The AutoSet for Her algorithm available on current devices applies different detection sensitivities calibrated to female respiratory patterns, which older devices did not offer.
The practical implication is that patients whose residual AHI on an M Series device is higher than expected, or whose data shows frequent flow limitations that are not being fully resolved, may see improved event control on a current device without any change to their prescribed pressure range. For patients whose therapy is well-controlled on an older device — low AHI, good compliance, minimal symptoms — the algorithm improvement is real but may not translate into meaningful clinical benefit.
Data Access and Remote Monitoring
This is arguably the area where the gap between the ResMed M Series CPAP and current devices is most pronounced from a practical standpoint. The S9 offered data recording and could be read via SD card, but its connectivity options were limited and its integration with patient-facing apps was rudimentary compared to current standards.
Current ResMed AirSense devices include built-in wireless cellular modems that transmit nightly data automatically to the myAir patient app and to the ResMed AirView platform used by sleep physicians and equipment suppliers. This means your compliance data, AHI, leak rate, pressure statistics, and event breakdown are available to you and your provider without SD card downloads or clinic visits.
For patients who want to actively engage with their therapy data — monitoring trends, identifying problems early, and sharing information with providers between appointments — the data access gap between an M Series device and a current device is substantial. For patients who are not interested in monitoring their own data and whose therapy is managed through periodic follow-up without remote monitoring, this difference is less consequential.
Noise Levels
CPAP noise has decreased meaningfully across device generations. The S9 was considered quiet at release, with noise levels in the range of 26 to 28 decibels. Current AirSense 10 and AirSense 11 devices are rated at approximately 26 to 27 decibels under standard conditions — a modest improvement in specification, but one that reflects better motor isolation, refined airflow management, and quieter overall operation in practice.
More significantly, current devices handle pressure transitions and leak responses more smoothly, which reduces the intermittent noise associated with the device adjusting to changing conditions. Patients whose partners are disturbed by CPAP noise may notice a more consistent, less variable sound profile with current equipment.
Humidification and Heated Tube Technology
The S9 with ClimateLineAir heated tube was genuinely effective at managing humidification and preventing rainout when used with compatible settings. The current AirSense 10 and 11 devices use an updated version of this system — the ClimateLineAir 10 — which offers improved temperature consistency along the tube length and better integration with the device’s climate control algorithms.
If your M Series device is being used with a non-heated tube, the improvement from switching to a current device with a compatible heated tube would be more noticeable than for patients already using heated tubing with their S9. The fundamental technology — warm air delivered through a heated hose to prevent condensation — is similar across generations, but the current implementation is more refined.
The Insurance and Prescription Process for Upgrading
Under Medicare and most commercial insurance plans, CPAP devices are eligible for replacement every five years. If your M Series device is more than five years old — which applies to virtually all S8 devices and many S9 devices at this point — you are likely eligible for a replacement device under your current coverage.
The process requires a current prescription from a licensed provider and documentation of medical necessity. If your original sleep study and prescription are significantly dated, your provider may request a new clinical assessment before generating an updated prescription, though this is not always required. Contacting your DME supplier with your insurance information is the most direct way to determine what documentation is needed and whether prior authorization is required before proceeding.
If your device continues to function but is approaching or past the five-year mark, initiating the replacement process proactively — rather than waiting for the device to fail — ensures continuity of therapy without gaps.
When Upgrading Makes Clear Sense
The case for upgrading from a ResMed M Series CPAP to a current device is strongest when your device is more than five years old and you are insurance-eligible for replacement, when your residual AHI is higher than it should be and better algorithm performance might improve control, when you want active data monitoring through a patient-facing app, when your device requires repairs that cost more than the replacement process would, or when mask and tubing compatibility is limiting your equipment options.
The case for continuing with a functioning M Series device is reasonable when your therapy is well-controlled, your compliance is good, your symptoms are resolved, and the process of obtaining a replacement is more burden than the upgrade would deliver in benefit. A functioning, well-maintained device that is producing good therapy outcomes does not need to be replaced before the insurance timeline requires it — but understanding what a replacement would offer helps you make that assessment on the basis of accurate information rather than assumption.